Test Price
1,100 AED✅ Home Collection Available
Factor V Leiden Mutation Analysis Test in UAE | 1100 AED
Executive Summary & Core Metrics
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) Accredited Processing using Real-Time PCR genotyping with allelic discrimination.
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain. VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- ✓ Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance for result interpretation by our expert genetics team.
- ✓ Insurance: Instant Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Factor V Leiden Mutation Analysis is a definitive pharmacogenetic test that detects the G1691A point mutation in the F5 gene, the most common inherited cause of thrombophilia. In the UAE population, this test is critical for assessing predisposition to venous thromboembolism (VTE), particularly for patients with a personal or family history of deep vein thrombosis, or for women with a history of recurrent pregnancy loss, guiding personalized anticoagulation therapy.
| Feature | Our Test (DNA Labs UAE) | Closest Alternative |
|---|---|---|
| Methodology | Real-Time PCR (qPCR) with Allelic Discrimination | Legacy PCR-RFLP or DNA Sequencing |
| Diagnostic Precision | Greater than 99.9% Sensitivity & Specificity for G1691A | Approximately 98% Sensitivity with potential for incomplete digestion |
| Turnaround Time | 3 Working Days | 5 to 10 Working Days |
Physician Insight & Safety Protocols
"The Factor V Leiden mutation result must always be correlated with the full clinical picture. A heterozygous carrier faces roughly a 3-fold to 8-fold elevated lifetime risk for a first venous thromboembolic event, while homozygous individuals carry a substantially higher risk. This genetic finding alone does not equate to a thrombosis diagnosis; comprehensive assessment of personal and family history is mandatory before any prophylactic antithrombotic therapy is considered."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
Critical Medication Advisory
Medication Safety Notice
Do not discontinue or alter any prescribed anticoagulant (e.g., Warfarin, Rivaroxaban, Apixaban) or other medication based solely on this genetic test result without explicit consultation with your managing physician. Abrupt changes can increase the risk of thromboembolic or hemorrhagic complications.
Safety Information, Exclusion Criteria & Emergency Red Flags
This test is not intended for standalone diagnosis of acute thrombosis. It is a genetic susceptibility test for inherited thrombophilia risk assessment only.
- Exclusion Criteria for Home Collection: Patients currently experiencing an acute thrombotic emergency, active unstabilized chest pain, or sudden shortness of breath must proceed directly to the Emergency Room.
- Sample Integrity: We strictly require 3 mL (2 mL minimum) whole blood collected in a Lavender Top (EDTA) tube. The sample must be shipped and maintained under refrigerated conditions (2-8 °C).
- Processing Constraint: DO NOT FREEZE the whole blood sample. Freezing causes cell lysis and DNA degradation leading to test failure and potential need for recollection.
- Emergency Red Flags: Seek immediate emergency care if you develop sudden unilateral leg swelling or pain, sudden severe chest pain, difficulty breathing, or coughing up blood. These may indicate Deep Vein Thrombosis or Pulmonary Embolism.
Patient FAQ & Clinical Guidance
1. What does a heterozygous Factor V Leiden result mean for my future health?
A heterozygous result indicates you carry one mutated copy of the F5 gene, conferring an approximately 3-fold to 8-fold increased lifetime risk for a first venous blood clot relative to the general population. This information empowers your physician to manage hormonal therapies, pregnancy, or surgical procedures with appropriate prophylactic measures. It is a risk factor, not a guaranteed diagnosis of thrombosis.
2. Is fasting required for this blood test and can I do it at home?
No special preparation or fasting is required for the Factor V Leiden genetic test, as your DNA sequence is unaffected by food intake or time of collection. Our ISO-certified VIP phlebotomy team can perform a smooth home collection directly from your arm between 8 AM and 11 PM using strict cold-chain protocols to preserve sample integrity.
3. How does this genetic test comply with UAE data privacy regulations?
Your genetic data is fully protected under the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All results are anonymized, encrypted, and accessible only to you and your designated healthcare provider through a secure digital platform.
4. Will my insurance cover the Factor V Leiden mutation analysis?
Coverage varies by insurance provider and policy. We offer instant direct billing verification via WhatsApp at +971 54 548 8731. Our team can confirm your eligibility and out-of-pocket costs before sample collection.
UAE Regulatory & Data Privacy Adherence
Data Protection & Regulatory Compliance
DNA Labs UAE operates under strict adherence to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is processed, stored, and transmitted using enterprise-grade encryption, with access restricted to authorized personnel only. Clinical safety and patient consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring full transparency and informed consent throughout the testing lifecycle.
Our DHA-licensed facility (License No. 1143) at Dubai Healthcare City undergoes regular audits to maintain compliance with all applicable UAE healthcare data standards and international best practices.
Clinical & Logistical Metadata
| Test Name | Factor V Leiden Mutation Analysis |
| Price (AED) | 1100 AED |
| Turnaround Time | 3 Working Days |
| Sample Type / Matrix | Whole Blood (EDTA Tube) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM |
| Methodology Used | Real-Time PCR (qPCR) with Allelic Discrimination |
| ICD-10-CM Code | D68.51 |
| LOINC Code | 21671-8 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians